Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, Internal Medicine, DABIM, M.D
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Endocrinology Diabetes and Metabolism)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Endocrinology Diabetes and Metabolism)
General Physician
M.B.B.S, MSc. in Diabetes and Endocrinology
Endocrinologist
MBBS, MCPS (Medicine), FCPS ( Medicine), FCPS (Endocrinology), SCE (Endocrinology & Diabetes, UK)
Endocrinologist
MBBS, MCPS (Medicine), FCPS ( Medicine), FCPS (Endocrinology), SCE (Endocrinology & Diabetes, UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Gastroenterologist
MBBS, FCPS (Gastroenterology), FCPS (Medicine)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Internal Medicine Specialist
MBBS, Diplomate American Board Internal Medicine, Diplomate American Board Endocrinology, Diabetes & Metabolism
Internal Medicine Specialist
MBBS, Diplomate American Board Internal Medicine, Diplomate American Board Endocrinology, Diabetes & Metabolism
Internal Medicine Specialist
MBBS, FCPS
Diabetologist
MD
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures